1. |
Maher TM, Bendstrup E, Dron L, et al. Global incidence and prevalence of idiopathic pulmonary fibrosis. Respir Res, 2021, 22(1): 197.
|
2. |
Ye Z, Hu Y. TGF-β1: Gentlemanly orchestrator in idiopathic pulmonary fibrosis (Review). Int J Mol Med, 2021, 48(1): 132.
|
3. |
Raghu G, Remy-Jardin M, Richeldi L, et al. Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med, 2022, 205(9): e18-e47.
|
4. |
Mei Q, Liu Z, Zuo H, et al. Idiopathic Pulmonary Fibrosis: An Update on Pathogenesis. Front Pharmacol, 2022, 12: 797292.
|
5. |
欧阳小荔, 彭红. 特发性肺纤维化预后的影响因素. 中国呼吸与危重监护杂志, 2021, 20(11): 824-830.
|
6. |
Wynn TA. Integrating mechanisms of pulmonary fibrosis. J Exp Med, 2011, 208(7): 1339-1350.
|
7. |
Raghu G, Remy-Jardin M, Myers JL, et al. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med, 2018, 198(5): e44-e68.
|
8. |
Raghu G, Collard HR, Egan JJ, et al. An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management. Am J Respir Crit Care Med, 2011, 183(6): 788-824.
|
9. |
Collard HR, Ryerson CJ, Corte TJ, et al. Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report. Am J Respir Crit Care Med, 2016, 194(3): 265-275.
|
10. |
Kim DS, Park JH, Park BK, et al. Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features. Eur Respir J, 2006, 27(1): 143-150.
|
11. |
Meliconi R, Andreone P, Fasano L, et al. Incidence of hepatitis C virus infection in Italian patients with idiopathic pulmonary fibrosis. Thorax, 1996, 51(3): 315-317.
|
12. |
Ueda T, Ohta K, Suzuki N, et al. Idiopathic Pulmonary Fibrosis and High Prevalence of Serum Antibodies to Hepatitis C Virus. Am Rev Respir Dis, 1992, 146(1): 266-268.
|
13. |
Irving WL, Day S, Johnston ID. Idiopathic Pulmonary Fibrosis and Hepatitis C Virus Infection. Am Rev Respi Dis, 1993, 148(6pt1): 1683-1684.
|
14. |
Kuwano K, Nomoto Y, Kunitake R, et al. Detection of adenovirus E1A DNA in pulmonary fibrosis using nested polymerase chain reaction. Eur Respir J, 1997, 10(7): 1445-1449.
|
15. |
Egan J, Woodcock A, Stewart J. Viruses and idiopathic pulmonary fibrosis. Eur Respir J, 1997, 10(7): 1433-1437.
|
16. |
Drake TM, Docherty AB, Harrison EM, et al. Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study. Am J Respir Crit Care Med, 2020, 202(12): 1656-1665.
|
17. |
Goto Y, Sakamoto K, Fukihara J, et al. COVID-19-Triggered Acute Exacerbation of IPF, an Underdiagnosed Clinical Entity With Two-Peaked Respiratory Failure: A Case Report and Literature Review. Front Med (Lausanne), 2022, 9: 815924.
|
18. |
Yagi K, Huffnagle GB, Lukacs NW, et al. The Lung Microbiome during Health and Disease. Int J Mol Sci, 2021, 22(19): 10872.
|
19. |
Dickson RP, Erb-Downward JR, Martinez FJ, et al. The Microbiome and the Respiratory Tract. Annu Rev Physiol, 2016, 78(1): 481-504.
|
20. |
Hilty M, Burke C, Pedro H, et al. Disordered Microbial Communities in Asthmatic Airways. PLoS One, 2010, 5(1): e8578.
|
21. |
Tipton L, Ghedin E, Morris A. The lung mycobiome in the next-generation sequencing era. Virulence, 2017, 8(3): 334-341.
|
22. |
Young JC, Chehoud C, Bittinger K, et al. Viral Metagenomics Reveal Blooms of Anelloviruses in the Respiratory Tract of Lung Transplant Recipients. Am J Transplant, 2015, 15(1): 200-209.
|
23. |
Wylie K M. The Virome of the Human Respiratory Tract. Clinics in Chest Medicine, 2017, 38(1): 11-19.
|
24. |
Tamayo-Trujillo R, Guevara-Ramírez P, Cadena-Ullauri S, et al. Human virome: Implications in cancer. Heliyon, 2023, 9(3): e14086.
|
25. |
Cao Z, Sugimura N, Burgermeister E, et al. The gut virome: A new microbiome component in health and disease. EBioMedicine, 2022, 81: 104113.
|
26. |
Tang YW, Johnson J E, Browning P J, et al. Herpesvirus DNA is consistently detected in lungs of patients with idiopathic pulmonary fibrosis. J Clin Microbiol, 2003, 41(6): 2633-2640.
|
27. |
Egan JJ, Adamali HI, Lok SS, et al. Ganciclovir antiviral therapy in advanced idiopathic pulmonary fibrosis: an open pilot study. Pulm Med, 2011, 2011: 1-5.
|
28. |
Moore BB, Moore TA. Viruses in Idiopathic Pulmonary Fibrosis. Etiology and Exacerbation. Ann Am Thora Soc, 2015, 12(Suppl 2): S186-S192.
|
29. |
Hewitt RJ, Molyneaux PL. The respiratory microbiome in idiopathic pulmonary fibrosis. Ann Transl Med, 2017, 5(12): 250-250.
|
30. |
Tong X, Su F, Xu X, et al. Alterations to the Lung Microbiome in Idiopathic Pulmonary Fibrosis Patients. Front Cell Infect Microbiol, 2019, 9: 149.
|
31. |
Li Y, Gao J, Wang G, et al. Latent cytomegalovirus infection exacerbates experimental pulmonary fibrosis by activating TGF-β1. Mol Med Rep, 2016, 14(2): 1297-1301.
|
32. |
Stewart JP, Egan JJ, Ross AJ, et al. The Detection of Epstein-Barr Virus DNA in Lung Tissue from Patients with Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med, 1999, 159(4 Pt 1): 1336–1341.
|
33. |
Manika K, Alexiou-Daniel S, Papakosta D, et al. Epstein-Barr virus DNA in bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis, 2007, 24(2): 134-140.
|
34. |
Wootton SC, Kim DS, Kondoh Y, et al. Viral Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med, 2011, 183(12): 1698-1702.
|
35. |
Ushiki A, Yamazaki Y, Hama M, et al. Viral infections in patients with an acute exacerbation of idiopathic interstitial pneumonia. Respir Investig, 2014, 52(1): 65-70.
|
36. |
Santos GC, Parra ER, Stegun FW, et al. Immunohistochemical detection of virus through its nuclear cytopathic effect in idiopathic interstitial pneumonia other than acute exacerbation. Braz J Med Biol Res, 2013, 46(11): 985-992.
|
37. |
Weng D, Chen XQ, Qiu H, et al. The Role of Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis. Mediators Inflamm, 2019, 2019: 5160694.
|
38. |
Calabrese F, Kipar A, Lunardi F, et al. Herpes Virus Infection Is Associated with Vascular Remodeling and Pulmonary Hypertension in Idiopathic Pulmonary Fibrosis. PLoS One, 2013, 8(2): e55715.
|